Rika Saito

Regulatory Affairs Practice – Japan

BACKGROUND

FOCUS AREAS

More than 30 years of experience in non-clinical development and is an expert in nonclinical pharmacokinetics and bioanalysis.

  • Non-Clinical Pharmacokinetics
  • Bioanalysis

As an expert in non-clinical pharmacokinetics, Rika Saito builds Japan’s development strategy regarding non-clinical studies to support PMDA consultation and J-NDA. She has extensive experience creating CTDs and responding to PMDA queries in non-clinical parts.

She has more than 30 years of experience in non-clinical development and is an expert in nonclinical pharmacokinetics and bioanalysis.

She builds Japan’s development strategy regarding nonclinical studies to support PMDA consultations and J-NDA. She has extensive experience creating dossiers for PMDA consultation, responses to PMDA queries, and CTDs in non-clinical parts. She can establish and maintain business relationships with clients, vendors, etc. She has also actively engaged in strategic customer development activities to support business development in recent years.

Ready for Regulatory Clarity?

Stay informed as the regulatory landscape evolves. 

Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.